Login Contact Us
Oct 2023, Vol 11, Issue 4
Advanced Search
How do you find the scientific quality of the published articles on our web site?

Original Article
Evaluation of Amniocentesis Results in Patients With High-Risk Cell-Free Fetal DNA
Raziyeh Mohammad Jafari1, Sara Masihi1, Hamid Galehdari2, Mahin Najafian1, Mojgan Barati1, Maryam Khosravani1
1Fertility, Infertility, and Perinatology Research Center, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2Department of Biology, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran

IJWHR 2023; 11: 178-181
DOI: 10.15296/ijwhr.2023.39
Viewed : 4108 times
Downloaded : 3161 times.

Keywords : Amniocentesis, Prenatal Diagnosis, cffDNA
Full Text(PDF) | Related Articles
Objectives: The present research was conducted to evaluate the accuracy of cell-free fetal DNA (cffDNA) in diagnosing chromosomal abnormalities and measure consistency in diagnostic results between this assay and amniocentesis.

Materials and Methods: This retrospective observational study recruited pregnant women presenting for Down’s syndrome screening. These women underwent the nuchal translucency ultrasound and their serum levels of pregnancy-associated plasma protein A and free beta-human chorionic gonadotropin were measured based on the aim of the study. Amniocentesis was administered in subjects with high or uncertain risk for fetal chromosomal abnormalities and cffDNA testing or the quadruple screen test in those with moderate risk. The women diagnosed as high-risk cases in cffDNA testing also underwent amniocentesis to confirm their diagnosis.

Results: Amniocentesis showed trisomy 21 as the most prevalent chromosomal abnormality in 66 (67.3%) cases, followed by trisomy 18 in 12 (12.2%) and trisomy 13 in 7 (7.1%). False-positive cffDNA results were obtained in 8 (8.2%) cases. The coefficient of agreement between these two tests was, however, obtained as 0.845 (P<0.0001), and their results were significantly correlated with each other (χ2=369, P<0.0001). Moreover, cffDNA was found to diagnose prenatal chromosomal abnormalities with a sensitivity of 100%, a specificity of 50%, a positive predictive value of 91.8%, and a negative predictive value of 100%.

Conclusions: Given the high sensitivity of cffDNA observed in diagnosing chromosomal abnormalities, this assay can play a key role as a non-invasive procedure in prenatal diagnoses.

Cite By, Google Scholar

Google Scholar

Articles by Mohammad Jafari R
Articles by Masihi S
Articles by Galehdari H
Articles by Najafian M
Articles by Barati M
Articles by Khosravani M


Articles by Sara Masihi
Articles by Hamid Galehdari
Articles by Mahin Najafian
Articles by Mojgan Barati
Articles by Maryam Khosravani

Submit Paper
Online Submission System
IJWHR ENDNOTE ® Style Tutorials Publication Charge Women's Reproductive Health Research Center About Journal
Publication Information
Published Article Statistics